Almirall
Stock
Stock
ISIN: ES0157097017
Ticker: ALM
ES0157097017
ALM
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 05.06.2025
$0.263
CHART BY
Frequently asked questions
What is Almirall's market capitalization?
The market capitalization of Almirall is $2.35B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Almirall's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Almirall is 201.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Almirall?
Almirall's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.0557. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Almirall's stock?
Currently, 12 analysts cover Almirall's stock, with a consensus target price of $13.89. Analyst ratings provide insights into the stock's expected performance.
What is Almirall's revenue over the trailing twelve months?
Over the trailing twelve months, Almirall reported a revenue of $1.12B.
What is the EBITDA for Almirall?
Almirall's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $211.35M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Almirall?
Almirall has a free cash flow of $145.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Almirall have, and what sector and industry does it belong to?
Almirall employs approximately 2,026 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Almirall's shares?
The free float of Almirall is 74.26M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.35B
- EPS (TTM)
- $0.0557
- Free Float
- 74.26M
- P/E ratio (TTM)
- 201.25
- Revenue (TTM)
- $1.12B
- EBITDA (TTM)
- $211.35M
- Free Cashflow (TTM)
- $145.14M
Pricing
- 1D span
- $10.96$11.13
- 52W span
- $8.274$11.40
Analyst Ratings
The price target is $13.89 and the stock is covered by 12 analysts.
Buy
12
Hold
0
Sell
0
Information
Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network(Europe), Marketing through Own Network(United States), Marketing by Licensees, Research and Development Activity, and Corporate and Manufacturing services segments. The company was founded in 1943 and is headquartered in Barcelona, Spain.
- Employees
- 2,026
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- ES0157097017
- Primary Ticker
- ALM
Knockouts
LSX Data · Fundamentals & EOD data from FactSet